Lateral Flow Assays

Lateral Flow Assays Market Outlook

The global lateral flow assays market was valued at approximately USD 6.42 billion in 2022 and is projected to reach around USD 11.08 billion by 2035, growing at a CAGR of 5.4% during the forecast period of 2025 to 2035. This growth can be attributed to the rising demand for rapid and accurate diagnostic tools in various sectors such as healthcare, veterinary science, and food safety. Furthermore, the increasing prevalence of infectious diseases and the growing emphasis on point-of-care testing is driving the adoption of lateral flow assays. The convenience, simplicity, and cost-effectiveness associated with these tests, along with significant advancements in technology, are also contributing to market expansion.

Growth Factor of the Market

One of the primary growth factors for the lateral flow assays market is the increasing focus on preventive healthcare. With a rising awareness regarding early disease detection, especially in infectious diseases, the demand for rapid diagnostic tests has surged. Additionally, the COVID-19 pandemic has accelerated the adoption of lateral flow testing as it provides quick results that are essential for effective patient management and public health responses. The rise in the aging population, which is more susceptible to various diseases, further propels the market growth as there is a higher need for efficient diagnostic tools. Moreover, innovations in lateral flow technology, including the integration of digital and mobile platforms for better analysis and results interpretation, have opened new avenues for market expansion. The growth of the biopharmaceutical sector and increasing investments in research and development also contribute significantly to the market's positive trajectory.

Key Highlights of the Market

• The lateral flow assays market is projected to grow at a CAGR of 5.4% from 2025 to 2035.
• Point-of-care testing is becoming increasingly popular due to its convenience and rapid results.
• The COVID-19 pandemic has significantly boosted the demand for rapid testing kits.
• Technological advancements are enhancing the accuracy and efficiency of lateral flow assays.
• Increased investments in R&D activities are expected to drive innovations in the market.

By Product Type

Kits:

The kits segment remains the largest contributor to the lateral flow assays market due to their extensive use in home testing and point-of-care settings. These kits include all necessary components, such as reagents, sample collection devices, and detailed instructions, providing a user-friendly approach for both healthcare professionals and consumers. The ease of use and straightforward interpretation of results make kits particularly appealing for individual home testing, especially in the context of infectious disease outbreaks. Additionally, manufacturers are continuously innovating and releasing more advanced kits that improve sensitivity and specificity, which further supports the segment's growth. As consumers increasingly prefer rapid testing solutions, the kits segment is expected to continue to dominate the lateral flow assays market.

Readers:

The readers segment is gaining traction as more healthcare facilities and diagnostic laboratories recognize the importance of enhancing the accuracy of lateral flow assays. These devices allow for digital interpretation of test results, minimizing human error associated with visual assessment. With the integration of smartphones and tablets in healthcare, many readers now offer compatibility with mobile devices, allowing healthcare professionals to track and analyze data in real-time. The growing need for precise and standardized results across different testing environments is driving innovations in reader technology. As such, the readers segment is projected to grow significantly, supported by advancements in digital health solutions.

Accessories:

The accessories segment, including sample collection devices, control solutions, and other supportive materials, plays a critical role in the overall functionality of lateral flow assays. Accessories ensure that tests are conducted efficiently and consistently, which is vital for accurate results. As the lateral flow assay market grows, the demand for high-quality accessories that enhance the testing process is also increasing. Manufacturers are focusing on developing innovative accessories that can improve the user experience and the reliability of tests. This segment is anticipated to expand as healthcare providers seek to optimize their testing capabilities through the use of superior accessories.

Digital/Mobile Lateral Flow Assays:

The emergence of digital and mobile lateral flow assays marks a significant advancement in the market, catering to the increasing demand for connectivity and data management. These tests incorporate advanced technologies, such as mobile apps and cloud-based data storage, allowing users to easily share results with healthcare providers. Digital lateral flow assays enhance result accuracy by providing analytics and trends based on collected data. As telemedicine continues to rise, the integration of mobile technology with lateral flow assays is becoming essential for effective remote patient monitoring and management. Consequently, this innovative product type is expected to witness substantial growth as it aligns with the broader shift towards digital health solutions.

By Application

Infectious Disease Testing:

Infectious disease testing is a dominant application area for lateral flow assays, primarily due to the ongoing threats posed by various pathogens. The ability to quickly detect infections such as COVID-19, influenza, and other viral or bacterial infections is critical for effective disease management. The rapid test results enable timely diagnosis and treatment, which is essential in controlling outbreaks. As public health initiatives increasingly focus on rapid response strategies for infectious diseases, the lateral flow assays used for this application are expected to show significant growth. Continuous innovations in assay development, aimed at improving accuracy and broadening the range of detectable pathogens, further enhance the segment's prospects.

Pregnancy & Fertility Testing:

The pregnancy and fertility testing segment has long been a cornerstone of the lateral flow assays market. Home pregnancy tests are widely accessible and provide quick results, making them the preferred choice for many individuals. The accuracy and ease of use of these tests have driven their popularity, allowing users to conduct tests in the privacy of their own homes. Additionally, advancements in fertility testing kits have opened new opportunities in this application area, as more individuals seek to monitor their reproductive health proactively. As awareness of family planning and reproductive health continues to rise, the demand for lateral flow assays in pregnancy and fertility testing is expected to expand.

Drug Development & Quality Testing:

Drug development and quality testing applications of lateral flow assays are gaining momentum as the pharmaceutical industry seeks efficient and precise testing methods. These assays are employed in various stages of drug development, from initial screening to quality control of pharmaceutical products. By providing rapid results, lateral flow assays enable quick decision-making, which is crucial in a competitive industry where time-to-market is essential. Furthermore, regulatory compliance and quality assurance requirements drive the need for reliable testing methods, positioning lateral flow assays as a key tool in drug development and quality testing arenas. This segment is anticipated to grow as the need for rigorous testing and validation in drug manufacturing increases.

Veterinary Diagnostics:

The application of lateral flow assays in veterinary diagnostics is an emerging area with strong growth potential. These tests are used for the rapid diagnosis of various animal diseases, which is crucial for effective treatment and management in veterinary medicine. The increasing focus on pet healthcare and the rise in livestock farming are contributing to the demand for efficient diagnostic solutions in this sector. Lateral flow assays offer veterinarians the ability to conduct tests directly in the field, providing immediate results and improving animal welfare. As the veterinary diagnostics market continues to evolve, the lateral flow assays application is expected to expand significantly.

Food Quality Testing:

Food quality testing is another important application area for lateral flow assays, as food safety becomes a top priority for consumers and regulatory authorities alike. These assays can quickly and effectively detect contaminants, pathogens, and allergens in food products, ensuring that they meet safety standards before reaching consumers. The rising public awareness regarding foodborne illnesses and the increasing importance of traceability in food supply chains are driving the adoption of lateral flow assays in this field. As food producers and manufacturers strive to maintain high-quality standards, the demand for rapid food quality testing solutions will likely continue to grow, positively impacting this application segment of the market.

By Distribution Channel

Hospitals & Clinics:

The hospitals and clinics segment constitutes a significant portion of the lateral flow assays market, as these institutions are primary users of diagnostic tests. Hospitals and clinics require rapid and reliable diagnostic tools to facilitate timely decision-making in patient care. Lateral flow assays are particularly useful in emergency departments, where quick results are essential for effective treatment. The increasing patient load and the need for efficient diagnostic solutions in hospitals and clinics are propelling the demand for lateral flow assays within this distribution channel. Furthermore, as healthcare providers seek to enhance patient outcomes and streamline workflows, the reliance on these rapid tests is expected to strengthen in the coming years.

Home Care:

The home care segment is experiencing rapid growth due to the rising trend of self-testing and home-based healthcare solutions. Consumers are increasingly interested in managing their health proactively, leading to a surge in demand for user-friendly lateral flow assays for at-home testing, such as pregnancy tests and rapid COVID-19 tests. The convenience of conducting tests in the comfort of one's home, along with the availability of accurate results within minutes, appeals to a broad audience. As telehealth and remote monitoring solutions become more integrated into healthcare, the home care segment is projected to expand significantly, supported by advancements in product design and user experience.

Diagnostic Laboratories:

Diagnostic laboratories represent a vital distribution channel for lateral flow assays, as they serve as central hubs for testing and analysis. These laboratories utilize lateral flow tests to complement traditional laboratory testing methods, providing rapid results for various applications, including infectious disease testing and drug screening. The efficiency of lateral flow assays allows diagnostic laboratories to enhance their service offerings and meet the growing demand for quick turnaround times. With constant advancements in laboratory technology and an increasing focus on point-of-care testing, this segment is poised for substantial growth in the lateral flow assays market.

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are essential players in the lateral flow assays market, as they employ these tests for research and development purposes. These companies utilize lateral flow assays in various applications, including drug development, quality control, and clinical trials. The ability to conduct rapid tests enables these companies to streamline their processes and make informed decisions based on timely data. As the pharmaceutical industry continues to innovate and expand, the demand for lateral flow assays from pharmaceutical and biotechnology companies is expected to rise, driven by the need for efficient and effective testing solutions throughout the drug development lifecycle.

Research Institutes:

Research institutes play a crucial role in advancing the field of lateral flow assays, as they conduct studies and develop new testing technologies. These institutions utilize lateral flow assays in a variety of research applications, ranging from biomedical research to environmental testing. The growing emphasis on research and development, particularly in the context of public health and safety, is driving the demand for innovative lateral flow assay solutions. As research institutes continue to explore new applications and enhance testing methodologies, their contributions to the lateral flow assays market will be significant, reflecting the ongoing importance of research in driving market growth.

By Sample Type

Blood:

The blood sample type is one of the most common types used in lateral flow assays, as it allows for the detection of various biomarkers, pathogens, and conditions. Blood-based lateral flow tests are widely utilized in clinical settings for rapid detection of infectious diseases such as HIV, dengue, and hepatitis. The simplicity of collecting blood samples, along with the immediate results provided by lateral flow assays, enhances their appeal for point-of-care testing. As medical professionals continue to seek efficient diagnostic solutions, the blood sample type segment is expected to witness sustained growth in the lateral flow assays market.

Urine:

The urine sample type is also extensively used in lateral flow assays, especially for applications such as pregnancy testing, drug screening, and monitoring kidney function. Urine tests are non-invasive and easy to administer, making them ideal for both clinical and home settings. The accuracy and reliability of urine-based lateral flow assays have propelled their popularity among consumers and healthcare providers alike. As public awareness around health monitoring continues to rise, the demand for urine sample type lateral flow assays is anticipated to grow, particularly in the context of home testing solutions.

Saliva:

Saliva is gaining popularity as a sample type for lateral flow assays, particularly due to its non-invasive nature and ease of collection. Saliva-based tests are increasingly used for applications such as infectious disease detection, hormonal testing, and genetic screening. The convenience of saliva sample collection has made these tests a preferred choice for many users, especially in at-home testing scenarios. As research supports the efficacy of saliva as a diagnostic medium, the saliva sample type segment is expected to expand within the lateral flow assays market, driven by advancements in testing technology and consumer demand for non-invasive testing options.

Other Samples:

The other samples segment encompasses a variety of sample types used in lateral flow assays, such as nasal swabs, fecal matter, and environmental samples. This segment is gaining traction as researchers and healthcare providers seek diverse testing options for various applications, including infectious disease detection and food safety testing. The versatility of lateral flow assays allows for the adaptation of testing methodologies to accommodate different sample types, thus broadening their applicability. As awareness around the importance of comprehensive testing solutions increases, the other samples segment is anticipated to grow alongside innovations in assay development.

By Region

North America holds a significant share of the lateral flow assays market, primarily driven by advancements in healthcare technology and a robust demand for rapid diagnostic solutions. The increasing prevalence of chronic and infectious diseases, along with rising investments in healthcare research and development, supports market growth in this region. The North American lateral flow assays market is anticipated to witness a CAGR of 5.0% from 2025 to 2035, reflecting the continued emphasis on point-of-care testing and personalized medicine. Additionally, the presence of leading players and a well-established healthcare infrastructure further bolster the region's dominance in the global market.

Europe is also a key region for the lateral flow assays market, supported by stringent regulations regarding food safety and diagnostics. The increasing focus on preventive healthcare and early disease detection is driving the adoption of lateral flow tests across various applications, including infectious disease testing and pregnancy diagnosis. The European lateral flow assays market is expected to grow steadily as public health initiatives encourage rapid testing solutions. As leading manufacturers expand their operations and invest in technological advancements, Europe will play a vital role in shaping the future of the lateral flow assays market.

Opportunities

The lateral flow assays market presents numerous opportunities for growth and innovation, particularly in the area of digital integration. The rising trend of telehealth and remote patient monitoring creates a significant demand for lateral flow assays that can easily connect with mobile applications and cloud-based systems. This integration allows healthcare providers to analyze data in real-time, enhancing patient care and diagnostics. As healthcare continues to evolve towards personalized medicine, there is ample potential for developing lateral flow assays that cater to specific needs, such as point-of-care applications for chronic diseases, which could substantially increase market penetration and consumer adoption.

Moreover, the increasing awareness of health and wellness among consumers is creating a favorable environment for lateral flow assays in the home care segment. As self-testing becomes more popular, manufacturers have the opportunity to develop user-friendly kits that cater to various health conditions, from infectious diseases to hormonal imbalances. This consumer-driven shift towards proactive health monitoring signifies a substantial opportunity for lateral flow assay companies to innovate and target the growing home care market. The potential for collaboration with digital health platforms and integration of artificial intelligence for test result interpretation further highlights the opportunities within this dynamic market landscape.

Threats

Despite the promising growth prospects, the lateral flow assays market faces certain threats that could hinder its progress. One significant concern is the potential for regulatory challenges and compliance issues regarding product approvals. The healthcare landscape is characterized by stringent regulations, and any changes in guidelines could delay the introduction of new products, impacting revenue streams for manufacturers. Additionally, the emergence of alternative diagnostic methods, such as molecular testing and PCR assays, presents a competitive threat to lateral flow assays, as these methods often provide higher sensitivity and specificity. Companies must continuously innovate to remain relevant and maintain their market share amidst evolving competition.

Furthermore, the quality control of lateral flow assays is critical, as inaccurate results can have severe implications for patient care. Instances of false positives or negatives can erode trust in these tests and impact their uptake among consumers and healthcare providers. Manufacturers must ensure rigorous quality assurance processes to mitigate such risks. Lastly, the challenge of product differentiation in a crowded market can limit growth opportunities, as consumers may struggle to identify the best options available. Companies must prioritize branding, marketing, and education to highlight the unique advantages of their products and foster consumer confidence.

Competitor Outlook

• Abbott Laboratories
• Thermo Fisher Scientific
• Roche Diagnostics
• BD (Becton, Dickinson and Company)
• Quidel Corporation
• Meridian Bioscience
• Fujifilm Holdings Corporation
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• OraSure Technologies, Inc.
• Wondfo Biotech Co., Ltd.
• GenBody Inc.
• Helena Laboratories
• Standard Diagnostics, Inc.
• Abingdon Health

The competitive landscape of the lateral flow assays market is characterized by a diverse range of players, spanning from established multinational corporations to emerging startups. Major companies are focusing on research and development to innovate and enhance their product offerings, which is essential for maintaining a competitive edge in this rapidly evolving market. Strategic partnerships and collaborations are also common, as companies seek to leverage the strengths of others to expand their portfolios and enter new market segments. In addition, the growing trend of mergers and acquisitions is reshaping the competitive dynamics, allowing companies to consolidate resources and expertise to meet the increasing demand for rapid diagnostic solutions effectively.

Notably, Abbott Laboratories stands out as a leader in the lateral flow assays market, particularly due to its extensive portfolio of rapid diagnostic tests, including those for infectious diseases such as COVID-19 and HIV. The company’s commitment to innovation and quality has solidified its position as a key player in the market. Similarly, Thermo Fisher Scientific has made significant investments in lateral flow technology, expanding its offerings to include a range of tests for various applications. The company's robust distribution channels and global reach enable it to effectively meet the growing demand for lateral flow assays across different regions.

Roche Diagnostics is another prominent competitor, known for its strong focus on developing high-quality and reliable diagnostic tests. The company’s dedication to research and development has led to the introduction of several advanced lateral flow assays, enhancing its market standing. Additionally, Quidel Corporation has gained recognition for its innovative approaches to rapid testing, particularly in the context of infectious diseases. Quidel’s products are designed to meet the evolving needs of healthcare professionals and consumers alike, positioning the company favorably in the competitive landscape of lateral flow assays.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 GenBody Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Abingdon Health
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 PerkinElmer, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Roche Diagnostics
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Quidel Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Helena Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Meridian Bioscience
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Thermo Fisher Scientific
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Wondfo Biotech Co., Ltd.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 OraSure Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Standard Diagnostics, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fujifilm Holdings Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Lateral Flow Assays Market, By Application
    • 6.1.1 Infectious Disease Testing
    • 6.1.2 Pregnancy & Fertility Testing
    • 6.1.3 Drug Development & Quality Testing
    • 6.1.4 Veterinary Diagnostics
    • 6.1.5 Food Quality Testing
  • 6.2 Lateral Flow Assays Market, By Sample Type
    • 6.2.1 Blood
    • 6.2.2 Urine
    • 6.2.3 Saliva
    • 6.2.4 Other Samples
  • 6.3 Lateral Flow Assays Market, By Product Type
    • 6.3.1 Kits
    • 6.3.2 Readers
    • 6.3.3 Accessories
    • 6.3.4 Digital/Mobile Lateral Flow Assays
  • 6.4 Lateral Flow Assays Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Home Care
    • 6.4.3 Diagnostic Laboratories
    • 6.4.4 Pharmaceutical & Biotechnology Companies
    • 6.4.5 Research Institutes

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Lateral Flow Assays Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Lateral Flow Assays market is categorized based on

By Product Type

• Kits
• Readers
• Accessories
• Digital/Mobile Lateral Flow Assays

By Application

• Infectious Disease Testing
• Pregnancy & Fertility Testing
• Drug Development & Quality Testing
• Veterinary Diagnostics
• Food Quality Testing

By Distribution Channel

• Hospitals & Clinics
• Home Care
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes

By Sample Type

• Blood
• Urine
• Saliva
• Other Samples

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Thermo Fisher Scientific
• Roche Diagnostics
• BD (Becton, Dickinson and Company)
• Quidel Corporation
• Meridian Bioscience
• Fujifilm Holdings Corporation
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• OraSure Technologies, Inc.
• Wondfo Biotech Co., Ltd.
• GenBody Inc.
• Helena Laboratories
• Standard Diagnostics, Inc.
• Abingdon Health